Only one study compared women with FHA-PCOM to patients with PCOS phenotype D; although this study revealed higher AMH levels in PCOS-D patients (8.4 ± 5.1 vs 6.9 ± 3.8 ng/ml), this difference failed to reach statistical significance ( P = 0.071) ( Beitl et al. , 2022 ).
← all excerpts
Functional hypothalamic amenorrhoea and polycystic ovarian morphology: a narrative review about an intriguing association.
1
0.0710
0.0710